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To dissect the molecular mechanisms conferring positional information in skeletal muscles, we characterized the control
elements responsible for the positionally restricted expression patterns of a muscle-speciﬁc transgene reporter, driven by
regulatory sequences from the MLC1/3 locus. These sequences have previously been shown to generate graded transgene
expression in the segmented axial muscles and their myotomal precursors, fortuitously marking their positional address. An
evolutionarily conserved E box in the MLC enhancer core, not recognized by MyoD, is a target for a nuclear protein complex,
present in a variety of tissues, which includes Hox proteins and Zbu1, a DNA-binding member of the SW12/SNF2 gene
family. Mutation of this E box in the MLC enhancer has only a modest positive effect on linked CAT gene expression in
transfected muscle cells, but when introduced into transgenic mice the same mutation elevates CAT transgene expression
in skeletal muscles, speciﬁcally releasing the rostral restriction on MLC-CAT transgene expression in the segmented axial
musculature. Increased transgene activity resulting from the E box mutation in the MLC enhancer correlates with reduced
DNA methylation of the distal transgenic MLC1 promoter as well as in the enhancer itself. These results identify an E box
and the proteins that bind to it as a positional sensor responsible for regional differences in axial skeletal muscle gene
expression and accessibility. © 1999 Academic Press
INTRODUCTION
Signiﬁcant progress has been made over the past few
years in deﬁning the molecular circuitry that gives rise to
skeletal muscle lineages in vertebrate embryos. Identiﬁca-
tion of transcription factors controlling the tissue- and
stage-speciﬁc expression of the myogenic phenotype has led
to the elucidation of regulatory pathways underlying the
generation of skeletal muscles from their mesodermal pre-
cursors during development.
Less is understood about the mechanisms responsible for
conferring positional identity on individual muscle groups
within the developing embryo and retaining these differ-
ences in the adult musculature. The complex and reproduc-
ible patterns of contractile tissues formed in the embryo,
and maintained in the adult, are likely to be speciﬁed by
common pathways patterning functionally related tissues,
such as nerves, tendon, and bone.
We have previously described a transgenic model that
responds to positional cues in developing skeletal muscles
along the mouse anteroposterior axis and maintains posi-
tionally restricted patterns of expression in adult muscula-
ture (Donoghue et al., 1991; Grieshammer et al., 1992).
Expression of a variety of transgene reporters, driven by a
1200-bp MLC1 promoter and a 920-bp downstream en-
hancer from the MLC1/3 locus, is graded in the developing
somites and retains a rostrocaudal gradient of expression in
1 Present address: SBGM Bat.142 CEA-Saclay, 91191 Gif-sur-
Yvette France.
2 Present address: Developmental Biology Institute of Marseille
Campus de Luminy Case 907 13288 Marseille Cedex 9 France.
3 Present address: Millenium Pharmaceuticals, Inc., Cambridge,
MA 02139.
4 Present address: Department of Anatomy, School of Medicine,
University of California, San Francisco, CA 94143–0452.
5 To whom correspondence should be addressed. Fax: (617) 724–
9561.
Developmental Biology 213, 217–229 (1999)
Article ID dbio.1999.9345, available online at http://www.idealibrary.com on
0012-1606/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved. 217the mature segmented axial muscle derivatives, highest in
posterior muscles (Donoghue et al., 1992a; Grieshammer et
al., 1992, 1993). This unique expression pattern is reﬂected
in the relative methylation of the transgenic MLC regula-
tory sequences (Donoghue et al., 1992b; Grieshammer et
al., 1995). Endogenous MLC1 gene expression and methyl-
ation are not graded in axial muscles (Grieshammer et al.,
1995), suggesting that the MLC sequences isolated in the
transgenic construct include a DNA module that, when
separated from its natural genomic milieu, responds to
regional regulators in muscles along the anteroposterior
axis.
To characterize the genetic components of this unusual
expression pattern, we sought to locate the cis-acting ele-
ments in the MLC regulatory sequences responsible for the
gradient in MLC transgene expression. Previous analysis of
the MLC enhancer has identiﬁed three E boxes, pairs of
which represent functional targets for myogenic factor
binding and enhancer activation (Wentworth et al., 1991)
but do not appear to contribute to the gradient in MLC
transgene expression (Rao et al., 1996). In considering other
candidate sequences, our attention was drawn to an up-
stream region of the MLC enhancer, containing a fourth E
box (CATGTG), adjoining an A/T-rich motif that includes
two consensus binding sites for Hox proteins (ATTA).
Sequences in this region of the MLC enhancer are perfectly
conserved for more than 30 bp between rat, mouse, and
human (Fig. 1A) (Rosenthal et al., 1990), suggesting that
they may play an important function in MLC1/3 regulation.
Proteins binding to this region include selected Hox pro-
teins (Houghton and Rosenthal, 1999) as well as Zbu1, a
novel DNA-binding member of the SWI2/SNF2 family of
transcriptional cofactors involved in chromatin conﬁgura-
tion (Gong et al., 1997). The Hox binding sites in the MLC
FIG. 1. (A) Sequence comparison of the MLC core enhancer from human, rat, and mouse. Muscle-speciﬁc regulatory elements (in boldface)
are the MyoD binding sites A, B, and C and the MEF-2 binding site A/T-rich region. A putative Hox protein binding site and an E box
element (BMW), are also shown in boldface. (B) A homologous BMW element is found in the kappa light chain enhancer and promoter
sequences.
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Hox proteins are involved in the establishment of posi-
tional identity in other somitically derived tissues, such as
the axial skeleton, and have been implicated in the regula-
tion of muscle patterning in both vertebrate and inverte-
brate embryos (reviewed in Olson and Rosenthal, 1994).
Surprisingly, mutation of the Hox sites in the transgenic
MLC enhancer did not lead to changes in the graded pattern
of transgene expression (Rao et al., 1996), suggesting that
other elements in the MLC transgene must be responsive to
regional differences in developing axial muscles.
In this report we demonstrate that the upstream E box
(termed BMW) adjoining the Hox binding sites in the MLC
enhancer acts as a weak negative regulatory element in
muscle cell lines. It does not bind MyoD, but instead is
recognized by a nuclear complex present in a variety of cell
types. In transgenic mice, mutation of the BMW box alone
is sufﬁcient to increase transgene expression in a variety of
muscle groups. The BMW mutation also releases the repres-
sion of an otherwise unmodiﬁed MLC transgene in anterior
axial muscles, signiﬁcantly diminishing the gradient both
in activity and in methylation of the MLC transgenic
sequences in axial musculature. These data implicate an E
box in the MLC enhancer, and the protein complex that
binds to it, as a positional sensor in the establishment of
regionally restricted muscle gene expression and accessibil-
ity along the anteroposterior axis.
MATERIAL AND METHODS
Plasmids and site-directed mutagenesis. The MSV-MyoD ex-
pression vector (Davis et al., 1987) was a gift from A. Lassar and H.
Weintraub. Plasmid MLC1CATBMW (abbreviated BMW in ﬁgures)
was generated by polymerase chain reaction (PCR) mutagenesis
(Libri et al., 1995) of pMLC1CAT920 (Rosenthal et al., 1989)
(abbreviated WT in ﬁgures). The BMW site was mutated at the
same residues shown by the methylation interference experiments
to be important for the binding of the BMW protein complex
(pBMW), using the following oligonucleotides:
BMWmut 59-TGAGCGGTTCACACTACCTAATTTAA-
TAAGGTTAGGTCC-39
59MLC 59-CGCGGATCCGCTATTAATCCC-39
39MLC 59-CGCGGATCCGAGCTTTAAGATAC-39
The mutagenic oligonucleotide (BMWmut), the 59MLC oligonucle-
otide, and 100 ng of the wild-type template (pMLC1CAT920) were
used to obtain a primary PCR product. A second PCR was per-
formed using as primers the primary PCR product and the oligo-
nucleotide 39MLC. The resulting PCR product was then cloned in
the BamHI sites of the reporter plasmid pMLC1CAT. Vent poly-
merase was used to minimize PCR error and the entire mutant
MLC enhancer was double-strand sequenced.
Transgenic mice. A 3.7-kb AccI fragment was excised from
pMLC1CATBMW expression cassettes (see Fig. 2) and injected into
pronuclei of fertilized mouse eggs as described by Hogan et al.
(1986). Potential founders were screened for transgene integration
by tail blotting with
32P-labeled CAT DNA probe (Rosenthal et al.,
1989). The three founder lines (BMW Nos. 3, 4, and 9) expressing
the transgene were established by mating positive animals to
(C57BL6 3 CBA) F1 mice. F1 progenies were checked for the
presence of the transgene by PCR ampliﬁcation of tail genomic
DNA with primers speciﬁc for the CAT gene. Transgene copy
number was determined by Southern blot (30–50 copies in BMW 3
and 4, ,5 copies in BMW 9) and by comparison to transgenic mice
carrying 40 copies of the wild-type MLC genomic fragment (line 7;
Grieshammer et al.). Line 7 was chosen as a representative wild-
type MLC-CAT line because it had a transgene copy number
comparable to that of the BMW mutant lines, and because it
expressed the MLC-CAT transgene at levels similar to those
measured in multiple independently derived MLC-CAT lines (see
Rosenthal et al., 1989).
Cell culture, DNA transfection, and CAT assays. NIH3T3
mouse ﬁbroblasts were propagated in Dulbecco’s modiﬁed Eagle
medium (DMEM) containing 10% fetal calf serum (FCS), 2%
glutamine, and 50 units/ml penicillin–streptomycin, and seeded for
transfection at 1 3 10
6 cells/100-mm plate. The C2C12 mouse
skeletal muscle cell line (Blau et al., 1985) was cultured in DMEM
supplemented with 20% FCS and seeded for transfections on
100-mm plates at 1 3 10
5 cells for myoblasts and 4 3 10
5 cells for
myotubes. Plasmids were transfected into NIH3T3 and C2C12
cells by calcium phosphate coprecipitation (Graham et al., 1975)
using 10 mg of reporter construct, 5 mg of MSV-myoD expression
vector, and 2 mg of a SV40-luciferase control plasmid. The medium
was changed after 16 h (DMEM containing 10% FCS for NIH3T3
cells, 20% FCS for myoblasts, and 2% horse serum for myotubes).
Forty-eight hours later, cells were harvested according to published
protocols (Rosenthal, 1987). Luciferase enzymatic assays were
carried out to normalize the amount of cell extract used for CAT
assays. CAT enzymatic assays were performed according to Seed
and Sheen (1988). For CAT assays on transgenic mice, mouse
tissues were dissected and frozen in dry ice, and protein extract was
prepared by successive cycles of freeze/thawing. CAT assays were
determined on adult heterozygotes (5 weeks or older). Three mice
from each founder line were analyzed. The amount of extract used
for the CAT assays was normalized to total protein content. CAT
assays were performed as described by Gorman et al. (1982). In Fig.
3, each experimental set was normalized to the EDL muscle (set to
100). MLC line 7 Absolute values for each muscle varied less than
103 between the four lines, with line 9 being the weakest expres-
sor. Relative values of absolute CAT activity for the four lines
(Nos. 3, 4, 7, 9) in masseter (a weakly expressing muscle) and EDL
(a strongly expressing muscle), expressed as fold difference in
absolute CAT activity, setting No. 7 masseter at 1, were as follows:
1,3,7,1 for masseter; 28, 45, 42, 11 for EDL.
Detection of genomic methylation. Preparation of genomic
DNA and quantitative analysis of transgene methylation were
performed essentially as described (Grieshammer et al., 1995),
using a ligation-mediated PCR procedure (McGrew and Rosenthal,
1993), with PCR programs shortened to 30 s for denaturation, 45 s
for annealing, and 30 s for extension. Analyses were performed on
multiple DNA samples prepared from at least three different
animals in each line, and were repeated at least twice for each
sample.
Electrophoresis mobility shift assay (EMSA) and methylation
interference footprinting. Binding and reaction conditions used
for EMSAs and methylation interference footprinting have been
described in Wentworth et al. (1991). Approximately 400 ng of
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used for EMSAs in a reaction volume of 20 ml containing 10 mM
Hepes (pH 7.9), 50 mM NaCl, and 1 mg of poly(d(I–C)). Nuclear
extracts from HeLa, C2C12, and NIH3T3 cell lines were prepared
by the method of Dignam et al. (1983). Jurkat, 70Z, and 70Z cells
treated with lipopolisaccharide (LPS) nuclear extracts were a gen-
erous gift of J. Sharon. Total protein concentration was determined
spectrophotometrically using a standard Bradford assay. To gener-
ate larger probes for EMSAs, fragments of the 173-bp MLC en-
hancer (see Fig. 5A, wt173 and mABC) were
32P end-labeled on the
sense or antisense strand of the vector pCAT173 at the polylinker
restriction sites (Wentworth et al., 1991). The following comple-
mentary oligonucleotides were synthesized:
BMW 20-mer 59-TCGACAAATTACCATGTGTG-39
BMW 59-GGACCTAACCTTATTAAATTACCATG-
TGTGAACCGCTCA-39
mBMW 59-GGACCTAACCTTATTAAATTAGGTAG-
TGTGAACCGCTCA-39
A5 9-GTCGCAGCAGGTGCA-39
C5 9-CGAAGCAACAGGTGCCT-39
AT 59-TTTTAAAAATAACTTTT-39
For EMSAs, the oligonucleotides listed above were annealed and
end-labeled with
32P using the Klenow fragment (Promega). In
competition experiments, double-stranded annealed oligonucleo-
tides were used at a 100-fold molar excess unless indicated other-
wise in the ﬁgure legends. For the methylation interference foot-
printing, the antisense fragment of the 173-bp MLC enhancer
(mABC) was
32P end-labeled as described in Wentworth et al.
(1991).
RESULTS
An E Box in the MLC Enhancer Acts
as a Negative Element
The MLC enhancer core presents a high degree of con-
servation between mouse, rat, and human over a region
that has been previously shown to be important for muscle-
speciﬁc expression both in tissue culture (Rosenthal, 1989;
Rosenthal et al., 1990; Wentworth et al., 1991) and in
transgenic mice (Rosenthal et al., 1989). Multiple con-
served regions in the MLC enhancer core constitute targets
for speciﬁc myogenic factors (Fig. 1A) including members
of the MyoD (sites A, B, and C) and MEF2 (A/T rich site)
families. In addition, a pair of consensus Hox protein
binding sites (CTTATTAAATTA) (Rao et al., 1996) and an
adjacent E box (CATGTG), termed BMW, also show a high
degree of conservation (Fig. 1A), suggesting a possible func-
tion in MLC enhancer activity.
To investigate whether the BMW box was involved in
enhancer-mediated transcriptional activation, an MLC en-
hancer variant in which the BMW motif was altered by
oligonucleotide-directed mutagenesis (Fig. 2A) was tested
for its ability to drive transcription from an otherwise
unmodiﬁed MLC1 promoter-CAT expression cassette in
transient transfections of C2C12 muscle and NIH3T3 ﬁbro-
blast cell lines. In NIH3T3 cells, muscle-speciﬁc activity of
both wild-type (WT) and mutant (BMW) MLC enhancers
was tested by transactivation with a cotransfected MyoD
expression vector. As previously shown (Wentworth et al.,
1991), MyoD efﬁciently transactivated wild-type MLC
enhancer-driven CAT gene expression. The BMW-mutated
enhancer responded to MyoD transactivation as strongly as
did the wild-type enhancer in NIH3T3 ﬁbroblasts (Fig. 2B,
top). In C2C12 differentiated myotubes, however, the BMW
mutation resulted in a twofold increase in CAT activity
over that driven by a WT enhancer (Fig. 2B, bottom). Thus,
unlike other E boxes in the MLC enhancer, the BMW box is
not a functional site for transactivation by MyoD and
appears to have a repressive role on the muscle-speciﬁc
action of the MLC enhancer.
Mutation of the BMW Box Releases the Gradient of
MLC-CAT Transgene Expression in Axial Muscles
To assess the function of the BMW box in vivo, where it
might affect temporal or spatial activation of linked re-
porter gene activity, transgenic mice were generated with
the MLC-CAT construct carrying the BMW mutation in the
downstream enhancer. Five germline-integrated founder
lines were established, and CAT transgene activity was
determined in protein extracts of muscle and liver tissue
from representative animals of the ﬁve lines. Two lines did
not express the transgene in either tissue. The other three
lines (BMW 3, 4, and 9) all expressed high levels of trans-
gene expression and were analyzed for CAT activity in
muscle and nonmuscle tissue. As shown in Fig. 3A, mice
carrying an MLC-CAT cassette driven by the wild-type
MLC enhancer expressed the transgene in a complex pat-
tern. As previously described (Donoghue et al., 1991; Grie-
shammer et al., 1992), transgene expression was low in the
masseter and diaphragm and graded in the intercostal
muscles, with very low expression levels in liver, lung,
spleen, stomach, and heart. In comparison, mice carrying an
FIG. 2. (A) Structure of the WT and BMW MLC-CAT expression cassette used in transfection experiments and to generate transgenic
mice. (B) MLC-CAT activity in nonmuscle (top) and muscle (bottom) cells transfected with wild-type and BMW-mutated MLC-CAT
transgenes. In NIH3T3 cells, MLC enhancer activity was tested by transactivation with a cotransfected MyoD expression vector. Value for
each bar is the average of at least three experiments (with standard error).
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retained muscle-speciﬁc transgene expression, but at a
consistently higher level, speciﬁcally in the masseter and
diaphragm. Moreover, the BMW mutation largely alleviated
CAT transgene repression in the rostral intercostal
muscles, which expressed 10- to 15-fold higher levels of
transgene activity compared with the wild-type transgene
(average values from all BMW lines is shown in Fig. 3B).
Thus the BMW box acts as a repressor of MLC transgene
expression, most notably in anterior axial muscle groups.
Positionally Restricted Methylation of Transgenic
MLC Regulatory Sequences Is Relieved by
Mutation of the BMW E Box
Multiple lines of evidence from this and other laborato-
ries (Donoghue et al., 1992b; Grieshammer et al., 1995)
have shown that positional differences in MLC-CAT trans-
gene expression, both in intact muscles and in primary
transgenic muscle cell cultures, cannot be attributed to
differences in transcriptional competence, but rather reﬂect
the extent of CpG methylation in both MLC1 promoter and
MLC enhancer sequences. Taken together, these studies
implicate selective methylation in the maintenance of
different gene expression patterns in skeletal muscles, and
establish the downstream enhancer of the MLC1/3 locus as
a target for epigenetic modiﬁcation.
To determine whether increases in MLC-CAT transgene
expression elicited by mutation of the BMW E box corre-
lated with changes in the methylation status of transgene
sequences, we examined methylation of selected CpG resi-
dues in the transgenic MLC1 promoter and MLC enhancer,
by a quantitative PCR-based analysis (Grieshammer et al.,
1995; McGrew and Rosenthal, 1993) of DNA from the
muscles of wild-type and BMW mutant lines. As seen in
Fig. 4, mutation of the BMW E box released the rostrocaudal
gradient of MLC enhancer methylation in intercostal
muscles, and resulted in demethylation of the enhancer in
selected muscles such as the diaphragm. Unexpectedly, the
effect of the BMW mutation was more pronounced on the
transgenic MLC1 promoter, which was signiﬁcantly less
methylated in rostral intercostal muscles, as well as in the
diaphragm and masseter. The changes in methylation of
CpGs in the proximal enhancer and distal promoter result-
ing from the BMW mutation correlated well with corre-
sponding changes in expression of the MLC-CAT transgene
(Fig. 3), supporting a role for methylation in the mainte-
nance of positional differences in MLC-CAT transgene
transcription.
The BMW Box Is Recognized by a Nuclear Protein
Complex but Not by MyoD
The results described above implicate the BMW E box,
and the proteins that bind to it, in the rostrocaudal gradient
of MLC-CAT transgene expression. Bacterially expressed
GST–MyoD fusion protein binds speciﬁcally to other E
boxes (A, B, and C) in the enhancer (Wentworth et al., 1991),
although MyoD-containing complexes derived from cell
extracts do not recognize the B box (Rosenthal et al., 1990),
presumably because it does not represent an optimal bind-
ing site for MyoD–E protein heterodimers (Huang et al.,
1996). The A, B, and C motifs appear to be the only bona
ﬁde MyoD binding sites in the enhancer, since a 173-bp
enhancer fragment in which all three sites were mu-
tagenized did not form a complex with GST–MyoD (Fig. 5A,
lane 2). As seen in Fig. 5B (lane 1), the GST–MyoD fusion
protein did not bind a 20-bp oligonucleotide probe contain-
ing the BMW site. Thus, the upstream BMW box is not a
target for MyoD in vitro.
Since previous DNase protection analysis of the MLC
enhancer with a HeLa cell extract revealed a footprint over the
BMW site (B. M. Wentworth and N.R., unpublished observa-
tions) gel shift assays with nuclear extracts from HeLa cells
were performed to identify nuclear protein complexes that
interact with this sequence. As seen in Fig. 5B, a protein–DNA
complex was observed with HeLanuclear extracts using the
BMW site as probe (lane 4). The speciﬁcity of this interaction
was conﬁrmed by competition experiments with a 100-fold
molar excess of unlabeled BMW oligonucleotide or an unre-
lated AT-rich oligonucleotide constituting the MEF2 site in
the MLC enhancer (Fig. 5B, lanes 5 and 6). To further demon-
strate the binding speciﬁcity of the HeLa protein complex
with the BMW site, competition experiments were carried out
using an excess of unlabeled oligonucleotides constituting the
E boxes in BMW, A or C sites (Fig. 5C, lanes 2–4). Only the
BMW E box was able to compete the binding of the HeLa
nuclear extract, while the E boxes in sites A and C could not.
The same sequence speciﬁcity of complex binding was ob-
served in gel shift assays using C2C12 nuclear extracts (data
not shown and see below). These results demonstrate that the
BMW E box in the MLC enhancer is recognized speciﬁcally by
a ubiquitous nuclear protein complex, termed pBMW, that is
different from that formed over sites A and C.
FIG. 3. Wild-type and BMW MLC-CAT transgene expression in adult skeletal muscle. (A) CAT assays were performed on protein extracts
from various adult tissues (IC, intercostal muscle; EDL, extensor digitalis longus) isolated from three independently generated BMW
MLC-CAT transgenic lines (BMW Nos. 3, 4, 9) and a wild-type MLC-CAT transgenic line (No. 7) (Grieshammer et al., 1992). (B) Expression
in the rostral intercostal muscle of three independent BMW-mutated MLC-CAT transgenic lines compared with wild type (WT, No. 7).
Values (with standard error) from three to six independent experiments were averaged and normalized to the expression of CAT in the EDL
(set to 100). Note the log scale of relative CAT activity. The shading density reﬂects the relative difference in CAT activity (see bottom of
the ﬁgure). The relative position of the muscle is indicated at the bottom: R, rostral; C, caudal.
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the BMW Box
The speciﬁc nucleotides in the MLC enhancer to which
pBMW binds were mapped by methylation interference assays
on an MLC enhancer fragment carrying mutations in sites A,
B, and C. Comparison of the methylation pattern seen on
the protein-bound DNA sample (Fig. 6A, lane B) with that
on free DNA (Fig. 6A, lane F) established positions of
protein–DNA interaction. As shown in Fig. 6A, pBMW
contacted two G residues on the antisense strand at the
BMW box. To further deﬁne the bases necessary for pBMW
binding, we generated a mutated oligonucleotide of 40 bp
(mBMW) containing the adjoining Hox and BMW sites in
the MLC enhancer. Mutations were introduced in the two
G residues shown to be important for the binding of pBMW
by methylation interference, and in two adjacent bases of
the E box element. EMSAs were carried out using a 40-bp
wild-type BMW probe and either wild type or the mBMW
oligonucleotide. As shown in Fig. 6B, the BMW complex in
C2C12 nuclear extracts was not competed by the unlabeled
mBMW oligonucleotide, even at 300-fold molar excess (Fig.
6B, lane 7), while a 50-fold molar excess of unlabeled BMW
oligonucleotide was sufﬁcient to compete for the binding of
this complex (Fig. 6B, lane 2). This analysis conﬁrms that
contact nucleotides identiﬁed by footprinting analysis of
the BMW box are essential for pBMW binding.
The BMW Protein Complex Is Abundant in
Undifferentiated Cell Types
A variety of cell lines were screened for the presence of the
pBMW complex by gel shift assays, using the BMW box as
probe. As shown in Fig. 7A, nuclear extracts from HeLa cells,
FIG. 4. Methylation of promoter and enhancer sequences in wild-type (WT) and BMW-mutated MLC-CAT transgenes. Demethylation in
the MLC enhancer (HhaI site) and in the MLC1 promoter (ThaI site) analyzed by LMPCR. Genomic DNA was isolated from adult tissues
(IC, intercostal muscle; EDL, extensor digitalis longus) in wild-type MLC-CAT and multiple BMW MLC-CAT lines described in Fig. 3.
Percentage demethylation was calculated as previously described (Grieshammer et al., 1995) from densitometric scans of labeled LMPCR
products analyzed by gel electrophoresis and autoradiography. Values (with standard error) from at least three independent experiments
were averaged. The gray shading reﬂects the relative levels of demethylation in each muscle group. The relative position of the muscles is
indicated at the bottom: R, rostral; C, caudal.
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Jurkat cells (a T-lymphocyte line) formed a protein complex of
the same mobility as pBMW, whereas L6 cells, 10T1/2, and
foreskin ﬁbroblasts (FS4) did not (data not shown). The rela-
tively low level of protein binding in extracts from C2C12
myotubes relative to C2C12 myoblasts (compare lanes 4 and
3 in Fig. 7A) suggests that pBMW might be more abundant in
undifferentiated cells, consistent with the negative regulatory
activity of the BMW box in differentiated myocytes. Similarly,
extracts from undifferentiated 70Z pre-B cells formed a
sequence-speciﬁc complex with the BMW probe (Fig. 7B, lanes
1–4), while the same complex was absent in nuclear extract
from 70Z cells differentiated into mature B cells by LPS
treatment (Fig. 7B, lane 5). Taken together, these results
suggest a general inhibitory function for the pBMW complex
in regulating differentiation-speciﬁc gene expression.
DISCUSSION
The BMW E Box Is a Positional Sensor
The discovery that transgenic reporters driven by reg-
ulatory elements from the MLC1/3 locus faithfully mark
the positional address in segmented axial muscles by
graded expression along the AP axis (Donoghue et al.,
1991; Grieshammer et al., 1992) provided an experimen-
tal model to investigate the molecular basis of regional
identity in these tissues. This avenue of investigation has
now led to the identiﬁcation of a single cis-acting ele-
ment in the MLC enhancer that responds to regional
regulators in the segmented axial muscles. Mutation of
the BMW E box in this element releases the rostral re-
striction of linked transgene expression and alters the
methylation of both proximal and distal regulatory se-
quences in the transgene.
Molecular studies of axial speciﬁcation in inverte-
brates have indicated that skeletal muscles within indi-
vidual body segments are speciﬁed by common pathways
involved in establishing segmental identity in other cell
types. The establishment of the embryonic body plan is
controlled at least in part by the homeodomain gene
family, which regulates downstream gene expression pro-
grams in spatially and temporally restricted patterns to
specify the body axes. Although a cell-autonomous role
for homeobox genes in the positional identity of Dro-
sophila muscles has been demonstrated (Michelson,
FIG. 5. (A) MLC enhancer fragments
32P-labeled wild type (wt173, lane 1) or mutated at the three MyoD binding sites (mABC, lane 2) were
combined with GST–MyoD bacterial fusion protein and analyzed by electrophoretic mobility shift assay. (B) GST–MyoD fusion protein
(lanes 1–3) or nuclear extracts from HeLa cells (lanes 4–6) were incubated with a
32P-labeled 20-bp oligonucleotide containing the BMW site.
Competition experiments were performed with 100-fold molar excess of unlabeled BMW oligonucleotide (lanes 2 and 5) or A/T-rich
oligonucleotide (lanes 3 and 6). (C) Nuclear extracts from HeLa cells were incubated with the 20-bp BMW probe and competition
experiments were carried out using 100-fold molar excess of unlabeled BMW oligonucleotide (lane 2) or oligonucleotides containing either
the A box (lane 3) or the C box (lane 4).
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positional speciﬁcity on segmented muscles in verte-
brates has been elusive, partly because it is more difﬁcult
to score morphological differences in muscles associated
with different vertebral segments than in the segmented
musculature of ﬂies (reviewed in Olson and Rosenthal,
1994). By identifying a positional sensor in vertebrate
muscle capable of modulating the accessibility of both
proximal and distal regulatory DNA sequences to the
transcriptional apparatus, this study provides a molecu-
lar model of regional regulation in skeletal muscle whose
mechanistic details can now be further dissected.
Role of Myogenic Factors in MLC-CAT
Transgene Expression
The characterization of proteins binding to the BMW box
suggests that it is not responsive to the MyoD family of
bHLH myogenic factors. Pathways distinct from those
responsible for the myogenic phenotype may therefore by
responsible for conferring positional identity on the mam-
malian axial musculature. Gene knockout phenotypes in-
dicate that at least some of these factors, such as myogenin,
are critical for establishment of differentiation-speciﬁc gene
expression programs, while others, such as myf5, specify
skeletal muscle lineages in the early embryo (Arnold and
Braun, 1996). None of the myogenic bHLH factors charac-
terized to date are likely to confer positional information in
the embryo, although they are clearly involved in establish-
ing muscle cell-speciﬁc patterns of gene expression, operat-
ing through other E boxes in the MLC enhancer. It is
therefore not surprising that a DNA regulatory element
that participates in positional sensing during embryonic
development should interact with factors other than those
belonging to the MyoD family.
The pBMW Complex and Repression
of Gene Activity
The pBMW nuclear protein complex deﬁned in this study
is potentially responsible for establishing positional infor-
mation through its interaction with an E box, a sequence
motif more commonly present in muscle control elements
as a target for myogenic bHLH factors. The possibility
remains that one of the unknown proteins in the pBMW
complex is actually a bHLH factor acting in concert with
other factors, such as Zbu1 and Hox proteins, which are
known to bind the BMW element (Gong et al., 1997; Rao et
al., 1996). The BMW sequence (CATGTG) diverges from
the optimal sequence for myogenic factors, binding as
heterodimers with E proteins (CAGGTG), although the
CANNTG core of the BMW box is identical to that of the
MCK enhancer Left-E box, which is similarly adjacent to an
A/T-rich site. In contrast to the BMW box, mutations of the
Left-E box lead to decreased expression in skeletal muscle
cells (Amacher et al., 1993). Notably, multimerized MCK
Left-E boxes are more active in NIH3T3 cells and in
myoblasts than multimerized MCK Right-E boxes which
contain the higher-afﬁnity MyoD binding site (Apone and
Hauschka, 1995).
Other sites to which the BMW box bears resemblence lie
in the regulatory elements of B-lymphocyte-speciﬁc genes.
A search of the kappa light chain locus for sequences
sharing homology to the BMW box revealed conserved
BMW-like motifs present in the kappa light chain promoter
(Boyd et al., 1986) and enhancer elements (Picard and
Schaffner, 1984) (Fig. 1B). The pBMW complex is present in
the pre-B cell line 70Z, but absent from 70Z cells treated
with LPS (see Fig. 7), which elicits cellular responses
leading to the expression of B-cell-speciﬁc genes such as the
kappa light chain immunoglobulin. It is therefore possible
FIG. 6. (A) Methylation interference footprinting of HeLa nu-
clear extract bound to the MLC enhancer mutated at sites A, B,
and C. The mABC enhancer fragment was labeled on the anti-
sense strand and binding to nuclear extracts was assayed by
methylation interference on bound (lane B) and free (lane F)
DNA. The footprint pattern is shown as well as the BMW site
(underline) near the F lane. (B) Nuclear extracts from C2C12
cells were incubated with a
32P-labeled 40-bp oligonucleotide
containing the HOX and BMW conserved regions of the MLC
enhancer core. Competition experiments were performed with
50 (lane 2)-, 100 (lane 3)-, and 200 (lane 4)-fold molar excess of
unlabeled 40-mer BMW oligonucleotide or with 100 (lane 5)-,
200 (lane 6)-, and 300 (lane 7)-fold molar excess of unlabeled
mBMW mutant oligonucleotide.
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targets for the pBMW complex, which may participate in
their repression, in either undifferentiated cells or, postmi-
totically, in nonpermissive tissue types.
Although the identity of each protein in the pBMW
complex has yet to be determined, previous studies indicate
that proteins from the Hox class of regulatory factors bind
directly to the BMW site and/or the adjoining AT-rich
motifs (Rao et al., 1996; Gong et al., 1997). These proteins
might be acting directly to specify positionally restricted
expression patterns on structural genes, as suggested by the
requirement for one of these proteins, Hoxc-8, in maximal
MLC-CAT transgene expression in selected muscles
(Houghton and Rosenthal, 1999). This would be an unor-
thodox role for clustered Hox genes, which have been
considered master regulators of the vertebrate body plan.
Hox gene products are unexpectedly abundant in neonatal
and adult muscle, however (Houghton and Rosenthal,
1999), and it remains to be seen whether they play a
secondary role in regulating structural genes in these tis-
sues during development or later in regeneration, perhaps
through interaction with intermediary factors that control
gene accessibility. Another protein previously character-
ized by its afﬁnity for the BMW site is Zbu1 (Gong et al.,
1997), a novel DNA-binding member of the SWI2/SNF2
family of transcription cofactors which have been impli-
cated in a number of DNA transactions such as chromatin
remodeling and transcription (Tsukiyama and Wu, 1997).
Originally isolated using the BMW box as a DNA target,
Zbu1 may have a more restricted DNA speciﬁcity in the
context of the pBMW complex. The uniformly high accu-
mulation of Zbu1 protein in postmitotic tissues such as
skeletal muscle, heart, and brain (S. Kaushal and N. R.
unpublished results) and the increased MLC-CAT trans-
gene expression resulting from mutation of its target BMW
box in the MLC enhancer (Fig. 3) suggest that Zbu1 may be
collaborating with other factors in the pBMW complex to
specify regional differences in gene accessibility in differen-
tiated tissues. Since Zbu1 itself is expressed relatively late
in embryonic development, and its transcripts are not
graded in axial muscles, it might play an ancillary role,
possibly through chromatin remodeling, to establish posi-
tional information in concert with other proteins that are
themselves differentially distributed.
FIG. 7. (A) Mobility shift assays were performed with nuclear extracts from HeLa cells (lane 1), NIH3T3 cells (lane 2), C2C12 myoblasts
(lane 3), myotubes (lane 4), and Jurkat cells (lane 5).
32P-labeled 20-mer BMW oligonucleotide was combined with the extracts and analyzed
by gel electrophoresis. (B) Nuclear extracts from the pre-B 70Z cells and mature B 70Z cells [after treatment with lipopolysaccharide (LPS)]
were incubated with the 20-bp BMW probe (lanes 1 and 5, respectively), and to assess the speciﬁcity of the complex formed by the 70Z
nuclear extracts, competition experiments were carried out using 100-fold molar excess of unlabeled BMW oligonucleotide (lane 2) or
oligonucleotides containing either the A box (lane 3) or the C box (lane 4).
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Regulatory Element
The most dramatic effect of the BMW mutation on
MLC-CAT transgene methylation is on the MLC1 pro-
moter, which would be situated several thousand bases
away from the MLC enhancer in either direction among
tandem arrays of MLC-CAT transcription units. The ability
of the BMW box to effect such distal changes in epigenetic
DNA modiﬁcation is similar to the action of other known
methylation regulators, speciﬁcally the one between the
H19 and IGF2 genes (Bartolomei and Tilghman, 1997;
Surani, 1998; Webber et al., 1998), where a short sequence
element has been identiﬁed as a regulator of parental
imprinting through selective methylation (Birger et al.,
1999). In the endogenous MLC1/3 locus, control of MLC1
promoter activity by methylation appears to be site speciﬁc,
since the internal MLC3 promoter is ubiquitously demeth-
ylated (McGrew et al., 1996). In contrast, control of MLC1
promoter activity by methylation is tissue speciﬁc, since
nonmuscle tissues, such as the heart, do not exhibit any
changes in the highly methylated state of MLC-CAT trans-
gene sequences carrying the BMW mutation (Fig. 4).
Although the relative chromatin conﬁguration of trans-
genic wild-type and mutant MLC sequences has yet to be
analyzed, a general cause-and-effect relationship between
DNA methylation and the regulation of gene accessibility
has been suggested by the interaction of the methyl CpG-
binding protein MeCP2 and histone deacetylase activity,
leading to acetylation of histones and transcriptionally
repressive chromatin (Eden et al., 1998; Jones et al., 1998;
Nan et al., 1998). Recent demonstration of the synergy
between demethylation and histone deacetylase inhibition
in the reactivation of gene expression in cancer (Cameron et
al., 1999) establishes a dynamic interaction between the
two processes, and further demonstrates the dominance of
DNA methylation in the stable maintenance of gene repres-
sion. Extrapolating these concepts to differentiation-
speciﬁc gene regulation would suggest that the release of
MLC-CAT transgene repression in selected skeletal
muscles by mutation of the BMW box is causally related to
the demethylation of promoter and enhancer sequences
seen in the transgene.
Speciﬁcation of Muscle Positional Identity by Gene
Accessibility
What is the function of the BMW box in the endogenous
MLC1/3 locus, where other regulatory sites with similar
protein binding capacities may exist? Although the steady-
state levels of transcripts from the endogenous MLC1/3
locus are not graded, increased activity of the BMW-
mutated MLC enhancer in muscle cell transfections sug-
gests a repressive role. The variable effect of the BMW
mutation on MLC-CAT transgene activity in different
muscle groups in vivo argues for a more complex role in
maintaining regional distinctions of structural gene expres-
sion. Variations in gene accessibility could be achieved
through the recognition of regulatory elements such as the
BMW box by speciﬁc DNA-binding protein complexes,
followed by local DNA methylation which may lock genes
into a silenced chromatin conﬁguration (Cameron et al.,
1999). Thus the fortuitous phenomenon of graded MLC-
CAT transgene expression provides a model for the molecu-
lar analysis of regional gene regulation. Although endoge-
nous muscle-speciﬁc genes regulated in this pattern have
yet to be identiﬁed, it follows that the initial abundance or
composition of the pBMW complex in different tissues may
determine the relative accessibility of speciﬁc genes to
transcriptional activation, perhaps through controlling
methylation patterns. From a survey of cell types where the
pBMW complex is present it appears that the complex may
be active while cells are still in a proliferative state. The
identiﬁcation of a molecular target for positional restriction
of transcriptional activity through epigenetic mechanisms
should hasten progress in elucidating general processes
underlying regional regulation of tissue-speciﬁc genes.
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